List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 38 studies with search of: Pheochromocytoma
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting A Broad Multi-histology Phase II Study of the Multi-Kinase Inhibitor R935788 (Fostamatinib Disodium) in Advanced Colorectal, Non-small Cell Lung, Head and Neck Hepatocellular and Renal Cell Carcinomas, and Pheochromocytoma and Thyroid Tumors (Multi-H...
Conditions: Head and Neck Neoplasms;   Pheochromocytoma;   Colorectal Neoplasms;   Carcinoma, Non-Small-Cell Lung;   Carcinoma, Renal Cell
Intervention: Drug: Fostamatinib disodium (R9355788)
2 Recruiting Content Validation of Quality of Life and Symptom Questionnaires for Pheochromocytoma and Paraganglioma
Conditions: Pheochromocytoma;   Paraganglioma
Intervention:
3 Completed Diagnosis and Treatment of Pheochromocytoma
Condition: Pheochromocytoma
Intervention:
4 Recruiting Diagnosis of Pheochromocytoma
Condition: Pheochromocytoma
Intervention:
5 Recruiting Study Of Sunitinib In Patients With Recurrent Paraganglioma/Pheochromocytoma
Conditions: Paraganglioma;   Pheochromocytoma
Intervention: Drug: Sunitinib
6 Recruiting A Study Evaluating Ultratrace Iobenguane I 131(MIBG)in Patients With Malignant Pheochromocytoma/Paraganglioma
Conditions: Pheochromocytoma;   Paraganglioma
Intervention: Radiation: Ultratrace Iobenguane I131
7 Completed I-123-MIBG for Imaging of Neuroblastoma and Pheochromocytoma
Conditions: Neuroblastoma;   Pheochromocytoma
Intervention:
8 Completed 131MIBG to Treat Malignant Pheochromocytoma
Condition: Pheochromocytoma
Interventions: Drug: [131]I-MIBG;   Drug: 6-[18F]Fluorodopamine;   Drug: [123]I-MIBG
9 Completed Meta-Iodobenzylguanidine (123I mIBG) Scintigraphy in Patients Being Evaluated for Phaeochromocytoma or Neuroblastoma
Conditions: Pheochromocytoma;   Neuroblastoma
Intervention: Drug: 123I-mIBG (meta-iodobenzylguanidine)
10 Recruiting Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
Conditions: Neuroblastoma;   Pheochromocytoma
Intervention: Radiation: iobenguane I 131
11 Active, not recruiting Phase 1-2 Study of Iobenguane (MIBG) I 131 in Patients With Malignant Pheochromocytoma/Paraganglioma
Conditions: Pheochromocytoma;   Paraganglioma
Intervention: Drug: Ultratrace Iobenguane (MIBG) I 131
12 Completed ULTRATRACE Iobenguane I 131 in Patients With Malignant Pheochromocytoma, Paraganglioma, or Metastatic Carcinoid
Conditions: Pheochromocytoma;   Paraganglioma;   Carcinoid
Intervention: Drug: Ultratrace iobenguane I 131
13 Completed Tumor Angiogenesis in Patients With Endocrine Tumors
Conditions: Adrenocortical Carcinoma;   Head and Neck Cancer;   Islet Cell Tumor;   Multiple Endocrine Neoplasia;   Neoplastic Syndrome;   Neuroblastoma;   Pheochromocytoma;   Von Hippel-Lindau Syndrome
Interventions: Genetic: DNA methylation analysis;   Genetic: in situ hybridization;   Genetic: microarray analysis;   Genetic: reverse transcriptase-polymerase chain reaction;   Other: immunohistochemistry staining method;   Other: laboratory biomarker analysis;   Procedure: biopsy
14 Recruiting Radiolabeled Octreotide in Treating Children With Advanced or Refractory Solid Tumors
Conditions: Brain and Central Nervous System Tumors;   Gastrointestinal Carcinoid Tumor;   Islet Cell Tumor;   Neuroblastoma;   Pheochromocytoma;   Sarcoma;   Unspecified Childhood Solid Tumor, Protocol Specific
Intervention: Radiation: yttrium Y 90-edotreotide
15 Active, not recruiting Surgery With or Without Chemotherapy in Treating Patients With Soft Tissue Sarcoma
Conditions: Endometrial Cancer;   Kidney Cancer;   Ovarian Cancer;   Pheochromocytoma;   Sarcoma
Interventions: Biological: filgrastim;   Drug: doxorubicin hydrochloride;   Drug: ifosfamide;   Drug: isolated perfusion;   Procedure: adjuvant therapy;   Procedure: conventional surgery;   Radiation: radiation therapy
16 Completed Combination Chemotherapy and Tamoxifen in Treating Patients With Solid Tumors
Conditions: Adrenocortical Carcinoma;   Brain and Central Nervous System Tumors;   Head and Neck Cancer;   Liver Cancer;   Malignant Mesothelioma;   Pheochromocytoma;   Sarcoma
Interventions: Drug: cisplatin;   Drug: doxorubicin hydrochloride;   Drug: tamoxifen citrate;   Procedure: conventional surgery;   Radiation: radiation therapy
17 Active, not recruiting Indium In 111 Pentetreotide in Treating Patients With Refractory Cancer
Conditions: Brain and Central Nervous System Tumors;   Childhood Langerhans Cell Histiocytosis;   Gastrointestinal Carcinoid Tumor;   Head and Neck Cancer;   Intraocular Melanoma;   Islet Cell Tumor;   Kidney Cancer;   Lung Cancer;   Melanoma (Skin);   Neoplastic Syndrome;   Neuroendocrine Carcinoma of the Skin;   Pheochromocytoma
Intervention: Radiation: indium In 111 pentetreotide
18 Recruiting Everolimus and Vatalanib in Treating Patients With Advanced Solid Tumors
Conditions: Gastrointestinal Carcinoid Tumor;   Head and Neck Cancer;   Islet Cell Tumor;   Kidney Cancer;   Lung Cancer;   Melanoma (Skin);   Neuroendocrine Carcinoma of the Skin;   Pheochromocytoma;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: everolimus;   Drug: vatalanib;   Genetic: protein expression analysis;   Other: high performance liquid chromatography;   Other: immunohistochemistry staining method;   Other: laboratory biomarker analysis;   Other: mass spectrometry;   Other: pharmacological study;   Procedure: dynamic contrast-enhanced magnetic resonance imaging;   Procedure: ultrasound imaging
19 Active, not recruiting Internal Radiation Therapy in Treating Patients With Liver Metastases From Neuroendocrine Tumors
Conditions: Head and Neck Cancer;   Islet Cell Tumor;   Metastatic Cancer;   Pheochromocytoma
Interventions: Drug: octreotide acetate;   Radiation: yttrium Y 90 resin microspheres
20 Active, not recruiting Surgery With or Without Combination Chemotherapy in Treating Patients With Lung Metastases From Soft Tissue Sarcoma
Conditions: Endometrial Cancer;   Kidney Cancer;   Metastatic Cancer;   Ovarian Cancer;   Pheochromocytoma;   Sarcoma
Interventions: Biological: filgrastim;   Drug: doxorubicin hydrochloride;   Drug: ifosfamide;   Procedure: conventional surgery

Previous Page Studies Shown (1-20) Next Page (21-38)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services